Health Trials

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

ConditionSurgical Wound
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Texas Health Science Center, Houston

About this trial

The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement

Eligibility criteria

Qualifiers

Has wound greater than or equal to 40cm2 requiring surgical debridement

Agreeable to follow up period of up to 1 year

Disqualifiers

Patients with wounds that do not require surgical debridement.

Patients with a known allergy or other sensitivity to fish material

Patients who are deemed unlikely to follow up (e.g., patients who live out of state).

Patients in police custody/incarcerated.

Trial design

Treatments tested in this trial

  • Fish Skin Graft (FSG)
  • Wound Vacuum-Assisted Closure (VAC)

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Source ClinicalTrials.gov